Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00178945 · ClinicalTrials.gov registry record · Phase 1
Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper Thoracic Muscular Pain
A Phase 1 study of Cervical Dystonia and Refractory Cervicothoracic Myofascial Pain Syndrome (CMPS), sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT00178945 is a Phase 1 study of Cervical Dystonia and Refractory Cervicothoracic Myofascial Pain Syndrome (CMPS) that has completed, run by Vanderbilt University. The registered enrollment target is 20 participants, below the 86-participant average among 15 other Cervical Dystonia trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00178945, a Phase 1 study of Cervical Dystonia and Refractory Cervicothoracic Myofascial Pain Syndrome (CMPS), has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the use of injections of Botox (botulinum toxin type A) for the treatment of chronic neck pain. Botox is an approved treatment for patients with cervical dystonia. Cervical dystonia is a chronic condition characterized by involuntary movements of the neck that are often painful. In this study, the response from Botox in patients with neck pain not associated with cervical dystonia will be compared to the pain response in patients with cervical dystonia.
Conditions Studied
Interventions
- DRUG Botulinum Toxin Type A
Study Locations (1)
Tennessee
- Vanderbilt Department of Neurology - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2004-03 |
| Est. Completion | 2006-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00178945
The ClinicalTrials.gov registry entry for NCT00178945 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 86-participant average among 15 other Cervical Dystonia trials with a reported enrollment target (77% lower). The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cervical Dystonia appearing as the primary indexed condition, and to 1 intervention - of which Botulinum Toxin Type A is the first listed.
NCT00178945 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT00178945 about?
NCT00178945 is a clinical study titled "Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper Thoracic Muscular Pain". The purpose of this study is to investigate the use of injections of Botox (botulinum toxin type A) for the treatment of chronic neck pain. Botox is an approved treatment for patients with cervical dystonia. Cervical dystonia is a chronic condition characterized by involuntary movements of the neck ...
What is the current status of trial NCT00178945?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2004-03. Estimated completion is 2006-03.
What conditions does trial NCT00178945 study?
This clinical trial studies the following conditions: Cervical Dystonia, Refractory Cervicothoracic Myofascial Pain Syndrome (CMPS).
What interventions are being tested in trial NCT00178945?
The interventions under investigation include: Botulinum Toxin Type A (DRUG).
Who is sponsoring clinical trial NCT00178945?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00178945 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Dystonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Deep Brain Stimulation to Treat Cervical Dystonia
COMPLETED · Phase 1
-
Safety and Tolerability of Perampanel in Cervical Dystonia
COMPLETED · Phase 1
-
A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults
RECRUITING · Phase 2
-
Safety and Effectiveness of Valbenazine as Adjunct Therapy to Botulinum Toxin Injections in Cervical Dystonia
RECRUITING · Phase 2
-
Effect of Vibro-tactile Stimulation Intensity on Head Posture in Cervical Dystonia
RECRUITING · NA
-
Zinc as an Adjunctive Therapy for Cervical Dystonia
RECRUITING · Phase 2
Explore more on PlainTrial
Cervical Dystonia
All registered trials for this condition
Refractory Cervicothoracic Myofascial Pain Syndrome (CMPS)
All registered trials for this condition
Tennessee
All trials with a study site in Tennessee
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.